Pharma & Biotech

Partnerships and programs

  • Enjoy competitive discounts on kits, reagents and other consumables
  • Use cutting-edge instruments from day one, thanks to flexible financing options
  • Receive special offers on digital analysis software tools and genomic services
  • Gain support for your research and business development with CDx capabilities and commercial opportunities
  • Customized enzymes, oligos and buffers in bulk from OEM by QIAGEN to help you accelerate your innovation

We understand the challenges of turning your company’s vision into a commercial success, so we’re on a mission to help make your journey a little easier.

Our Biotech Grant offers start-ups in North America and Europe the chance to get a grant worth up to $100,000 in products and instruments per region.

We plan to open the grant for applications in the future, so stay tuned for updates. You can also check out the 2021 recipients below.

Brick Built Therapeutics

BrickBuilt Therapeutics develops novel microbiome-focused treatments to transform oral health.

Using Live Biotherapeutic Products (LBPs), they propose to eliminate pathogens and build a healthy oral microbial community that will alleviate systemic diseases associated with poor oral health.

Glyphic biotechnologies

Glyphic biotechnologies is pioneering a first-of-its-kind next-generating sequencing platform for proteins.

No technology currently exists that can sequence the amino acids of proteins at the single-molecule level. Billions of proteins from a sample are captured simultaneously. This platform has the potential to provide us with a deeper understanding of human biology and, ultimately, the information needed for the development of novel therapeutics.

RheumaGen

RheumaGen is advancing a gene-editing technology that permanently halts rheumatoid arthritis (RA).

Stem-cell enriched blood is drawn from the body, and a single nucleotide is edited to prevent uncontrolled inflammation. The edited stem cells are reintroduced via a transfusion, and the immune response that leads to RA is reverted.

OncoBone Therapeutics

EU winner OncoBone Therapeutics aims to provide novel therapies for cancer patients with incurable bone metastases.

They are experts in osteoimmuno-oncology, the interactions between the bone, immune cells and tumor cells in the metastatic bone environment.

If you would like to find out more about this grant and the winners, read the press release.

Unlock the full potential of your R&D
Empower your team with our Biotech Accelerator Package, which includes five industry-leading software applications and databases developed for biotech, translational research and pharma.

Deciding whether to manufacture your product in-house or look for a commercial partner is challenging. You need a trusted partner that can assist you in rapidly bringing your product to the market. We understand that you need materials of a consistently high standard, supply chains that won’t let you down, and a partner that can routinely deliver in an uncertain world. 

OEM by QIAGEN offers manufacturing solutions for all your PCR kitting needs – regardless of scale. We offer a wide range of components, including custom solutions for nucleic acid purification, enzymes, oligonucleotides and PCR master mixes. We have GMP, ISO certification and manufacturing facilities worldwide, ensuring commercial excellence.